Table 1 Characteristics of patients and controls
Patients (n = 50) | Controls (n = 40) | |
|---|---|---|
Age – years | 53.1 (14.9) | 50.3 (12.8) |
Weight – kg | 87.1 (16.5) | - |
Time after intake – minutes | 130.1 (14.9) | - |
Platelet count – x 109/L | 142.6 (54.7) | 171.8 (54.3) |
Platelet count in PRP – x 109/L | 146.3 (44.5) | 152.4 (26.0) |
Rivaroxaban dose (mg od) | 20 | 0 |
Sex (female) | 26 (52%) | 24 (60%) |
Deep vein thrombosis | 21 (42%) | - |
Pulmonary embolism | 28 (56%) | - |
Atrial fibrillation | 1 (2%) | - |